Lundbeck/Myriad Marriage: Short But Not Sweet

Phase III data on Alzheimer’s disease candidate Flurizan comes up short.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet